Food and Drug Administration
Anesthetic & Life Support Drugs Advisory Committee
May 16, 2002
Slides
General Regulatory Issues in the Development of Drugs Intended for Treatment of Chronic Illness, Dr. Sharon Hertz, MD, FDA htm ppt
Specific Clinical/Regulatory Issues in Development of Drugs for Peripheral Neuropathy and Neuropathic Pain, Dr. Gerald Dal Pan, MD, MHS, FDA htm ppt
Diabetic Neuropathy, Dr. Eva Feldman, MD htm ppt
Electrophysiological Tests Used in the Evaluation of Peripheral Neuropathy and Neuropathic Pain, Dr. David Cornblath, MD, Johns Hopkins htm ppt
Neuropathic Pain: Is It All the Same from a Treatment Perspective?, Mark Rowbotham, MD htm ppt
Evidence That Supports Separate Neuropathic Pain Indications, Dr Robert Dworkin, PhD htm ppt
Open Public Hearing
Analgesic Drug Development for Neuropathic Pain, Dr. Najib Babul, PharmD, TheraQuest Biosciences htm ppt